|
1
|
Sharma SK, Mroz P, Dai T, Huang YY, St
Denis TG and Hambin MR: Photodynamic therapy for cancer and for
infections: What is the difference? Isr J Chem. 52:691–705.
2012.
|
|
2
|
Brown SB, Brown EA and Walker I: The
present and future role of photodynamic therapy in cancer
treatment. Lancet Oncol. 5:497–508. 2004.
|
|
3
|
Allison RR, Mota HC and Sibata CH:
Clinical PD/PDT in North America: an historical review.
Photodiagnosis Photodyn Ther. 1:263–277. 2004.
|
|
4
|
Dougherty TJ: Photodynamic therapy (PDT)
of malignant tumors. Crit Rev Oncol Hematol. 2:83–116. 1984.
|
|
5
|
Hayata Y, Kato H, Konaka C, et al:
Photoradiation therapy with hematoporphyrin derivative in early and
stage 1 lung cancer. Chest. 86:169–177. 1984.
|
|
6
|
McCaughan JS Jr, Ellison EC, Guy JT, et
al: Photodynamic therapy for esophageal malignancy: a prospective
twelve-year study. Ann Thorac Surg. 62:1005–1010. 1996.
|
|
7
|
Cheung J, Todd M, Turnbull R, et al:
Longer term assessment of photodynamic therapy for Intimal
Hyperplasia: a pilot Study. J Photochem Photobiol B. 73:141–147.
2004.
|
|
8
|
Cheung G, Sahai A, Billia M, Dasgupta P
and Khan MS: Recent advances in the diagnosis and treatment of
bladder cancer. BMC Med. 11:132013.
|
|
9
|
Bhowmick R and Girotti AW: Pro-survival
and pro-growth effects of stress-induced nitric oxide in a prostate
cancer photodynamic therapy model. Cancer Lett. 343:115–122.
2014.
|
|
10
|
Hwang H, Biswas R, Chung PS and Ahn JC:
Modulation of EGFR and ROS induced cytochrome c release by
combination of photodynamic therapy and carboplatin in human
cultured head and neck cancer cells and tumor xenograft in nude
mice. J Photochem Photobiol B. 128:70–77. 2013.
|
|
11
|
Rigual N, Shafirstein G, Cooper MT, et al:
Photodynamic therapy with 3-(1′-Hexyloxyethyl) pyropheophorbide a
for cancer of the oral cavity. Clin Cancer Res. 19:6605–6613.
2013.
|
|
12
|
Shi L, Wang X, Zhao F, et al: In vitro
evaluation of 5-aminolevulinic acid (ALA) loaded PLGA
nanoparticles. Int J Nanomedicine. 8:2669–2676. 2013.
|
|
13
|
Allison RR and Moghissi K: Photodynamic
therapy (PDT): PDT mechanisms. Clin Endosc. 46:24–29. 2013.
|
|
14
|
Matsubara T, Kusuzaki K, Matsumine A,
Shintani K, Satonaka H and Uchida A: Acridine orange used for
photodynamic therapy accumulates in malignant musculoskeletal
tumors depending on pH gradient. Anticancer Res. 26:187–193.
2006.
|
|
15
|
Sibata CH, Colussi VC, Oleinick NL and
Kinsella TJ: Photodynamic therapy in oncology. Expert Opin
Pharmacother. 2:917–927. 2001.
|
|
16
|
Oleinick NL, Morris RL and Belichenko I:
The role of apoptosis in response to photodynamic therapy: what,
where, why, and how. Photochem Photobiol Sci. 1:1–21. 2002.
|
|
17
|
Igney FH and Krammer PH: Death and
anti-death: tumour resistance to apoptosis. Nat Rev Cancer.
2:277–288. 2002.
|
|
18
|
Oleinick NL and Evans HH: The photobiology
of photodynamic therapy: cellular targets and mechanisms. Radiat
Res. 150(5 Suppl): S146–S156. 1998.
|
|
19
|
Ding X, Xu Q, Liu F, et al:
Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells
by means of reactive oxygen species production and cytosolic free
calcium concentration elevation. Cancer Lett. 216:43–54. 2004.
|
|
20
|
Henderson BW and Donovan JM: Release of
prostaglandin E2 from cells by photodynamic treatment in vitro.
Cancer Res. 49:6896–6900. 1989.
|
|
21
|
Castano AP, Demidova TN and Hamblin MR:
Mechanisms in photodynamic therapy: part three - photosensitizer
pharmacokinetics, biodistribution, tumor localization and modes of
tumor destruction. Photodiagnosis Photodyn Ther. 2:91–106.
2005.
|
|
22
|
Castano AP, Demidova TN and Hamblin MR:
Mechanisms in photodynamic therapy: part two - cellular signaling,
cell metabolism and modes of cell death. Photodiagnosis Photodyn
Ther. 2:1–23. 2005.
|
|
23
|
Henderson BW and Dougherty TJ: Review
article: How does photodynamic therapy work? Photochem Photobiol.
55:145–157. 1992.
|
|
24
|
Kurohane K, Tominaga A, Sato K, North JR,
Namba Y and Oku N: Photodynamic therapy targeted to tumor-induced
angiogenic vessels. Cancer Lett. 167:49–56. 2001.
|
|
25
|
Allison RR, Downie GH, Cuenca R, Hu XH,
Childs CJ and Sibata CH: Photosensitizers in clinical PDT.
Photodiagnosis Photodyn Ther. 1:27–42. 2004.
|
|
26
|
De Rosa FS and Bentley MV: Photodynamic
therapy of skin cancers: sensitizers, clinical studies and future
directives. Pharm Res. 17:1447–1455. 2000.
|
|
27
|
Allison RR and Sibata CH: Oncologic
photodynamic therapy photosensitizers: a clinical review.
Photodiagnosis Photodyn Ther. 7:61–75. 2010.
|
|
28
|
Vrouenraets MB, Visser GW, Snow GB and van
Dongen GA: Basic principles, applications in oncology and improved
selectivity of photodynamic therapy. Anticancer Res. 23:505–522.
2003.
|
|
29
|
Kennedy JC and Pottier RH: Endogenous
protoporphyin IX, a clinically useful photosensitizer for
photodynamic therapy. J Photochem Photobiol B. 14:275–292.
1992.
|
|
30
|
Burch S, Boqaards A, Siewerdsen J, et al:
Photodynamic therapy for the treatment of metastatic lesions in
bone: studies in rat and porcine models. J Biomed Opt.
10:0340112005.
|
|
31
|
Huang Z: A review of progress in clinical
photodynamic therapy. Technol Cancer Res Treat. 4:283–293.
2005.
|
|
32
|
Agostinis P, Berg K, Cengel KA, Foster TH,
Girotti AW, et al: Photodynamic therapy of cancer: an update. CA
Cancer J Clin. 61:250–281. 2011.
|
|
33
|
Castano AP, Demidova TN and Hamblin MR:
Mechanisms in photodynamic therapy: part one - photosensitizers,
photochemistry and cellular localization. Photodiagnosis Photodyn
Ther. 1:279–293. 2004.
|
|
34
|
Ochsner M: Light scattering of human skin:
a comparison between zinc (II)-phthalocyanine and photofrin II. J
Photobiol B. 32:3–9. 1996.
|
|
35
|
Robertson CA, Evans DH and Abrahamse H:
Photodynamic therapy (PDT): a short review on cellular mechanisms
and cancer research applications for PDT. J Photochem Photobiol B.
96:1–8. 2009.
|
|
36
|
Satonaka H, Kusuzaki K, Matsubara T,
Shintani K, Wakabayashi T, Nakamura T, et al: Flash wave light
strongly enhanced the cytocidal effect of photodynamic therapy with
acridine orange on a mouse osteosarcoma cell line. Anticancer Res.
27:3339–3344. 2007.
|
|
37
|
Alexiades-Armenakas M: Laser-mediated
photodynamic therapy. Clin Dermatol. 24:16–25. 2006.
|
|
38
|
Hamblin MR, Rajadhyaksha M, Momma T,
Soukos NS and Hasan T: In vivo fluorescence imaging of the
transport of charged chlorin e6 conjugates in a rat orthotopic
prostate tumour. Br J Cancer. 81:261–268. 1999.
|
|
39
|
Kurohane K, Tominaga A, Sato K, North JR,
Namba Y and Oku N: Photodynamic therapy targeted to tumor-induced
angiogenic vessels. Cancer Lett. 167:49–56. 2001.
|
|
40
|
Seshadri M, Spernyak JA, Mazurchuk R,
Camacho SH, Oseroff AR, Cheney RT and Bellnier DA: Tumor vascular
response to photodynamic therapy and the antivascular agent
5,6-dimethylxanthenone-4-acetic acid: implications for combination
therapy. Clin Cancer Res. 11:4241–4250. 2005.
|
|
41
|
Rasalkar DD, Chu WC, Lee V, Paunipagar BK,
Cheng FW and Li CK: Pulmonary metastases in children with
osteosarcoma: characteristics and impact on patient survival.
Pediatr Radiol. 41:227–236. 2011.
|
|
42
|
Tian Z, Quan X, Xu C, Dan L, Guo H and
Leung W: Hematoporphyrin monomethyl ether enhances the killing
action of ultrasound on osteosarcoma in vivo. J Ultrasound Med.
28:1695–1702. 2009.
|
|
43
|
Nomura L, Yanase S, Matsumura Y, Nagai K
and Tagawa T: Efficacy of combined photodynamic and hyperthermic
therapy with a new light source in an in vivo osteosarcoma tumor
model. J Clin Laser Med Surg. 22:3–8. 2004.
|
|
44
|
Hashiguchi S, Kusuzaki K, Murata H, et al:
Acridine orange excited by low-dose radiation has a strong
cytocidal effect on mouse osteosarcoma. Oncology. 62:85–93.
2002.
|
|
45
|
Messmann H, Knuchel R, Baumler W, et al:
Endoscopic fluorescence detection of dysplasia in patients with
Barrett’s esophagus, ulcerative colitis, or adenomatous polyps
after 5-aminolevulinic acid-induced protoporphyrin IX
sensitization. Gastrointest Endosc. 49:97–101. 1999.
|
|
46
|
Stübel H: The fluorescence of animal
tissues in ultraviolet light. Pflüger’s Archiv für die gesamte
Physiologie des Menschen und der Tiere. 142:1–14. 1911.(In
German).
|
|
47
|
Kusuzaki K, Suginoshita T, Minami G, et
al: Fluorovisualization effect of acridine orange on mouse
osteosarcoma. Anticancer Res. 20:3019–3024. 2000.
|
|
48
|
Kusuzaki K, Aomori K, Suginoshita T, et
al: Total tumor cell elimination with minimum damage to normal
tissues in musculoskeletal sarcomas following photodynamic therapy
with acridine orange. Oncology. 59:174–180. 2000.
|
|
49
|
Kusuzaki K, Murata H, Matsubara T,
Satonaka H, Wakabayashi T, Matsumine A and Uchida A: Review.
Acridine orange could be an innovative anticancer agent under
photon energy. In vivo. 21:205–214. 2007.
|
|
50
|
Satonaka H, Kusuzaki K, Matsubara T,
Shintani K, Wakabayashi T, Matsumine A and Uchida A: Extracorporeal
photodynamic image detection of mouse osteosarcoma in soft tissues
utilizing fluorovisualization effect of acridine orange. Oncology.
70:465–473. 2006.
|
|
51
|
Kusuzaki K, Murata H, Matsubara T, et al:
Clinical trial of photodynamic therapy using acridine orange
with/without low dose radiation as new limb salvage modality in
musculoskeletal sarcomas. Anticancer Res. 25:1225–1235. 2005.
|
|
52
|
Matsubara T, Kusuzaki K, Matsumine A,
Satonaka H, Shintani K, Nakamura T and Uchida A: Methylene blue in
place of acridine orange as a photosensitizer in photodynamic
therapy of osteosarcoma. In Vivo. 22:297–303. 2008.
|
|
53
|
Hickman JA: Apoptosis and tumourigenesis.
Curr Opin Genet Dev. 12:67–72. 2002.
|
|
54
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000.
|
|
55
|
Springfield DS: Introduction to
limb-salvage surgery for sarcomas. Orthop Clin North Am. 22:1–5.
1991.
|
|
56
|
Kusuzaki K, Aomori K, Suginoshita T, et
al: Total tumor cell elimination with minimum damage to normal
tissues in musculoskeletal sarcomas following photodynamic therapy
with acridine orange. Oncology. 59:174–180. 2000.
|
|
57
|
Kusuzaki K, Murata H, Takeshita H, et al:
Intracellular binding sites of acridine orange in living
osteosarcoma cells. Anticancer Res. 20:971–975. 2000.
|
|
58
|
Wright EH, Gwilym S, Gibbons CL, Critchley
P and Giele HP: Functional and oncological outcomes after
limb-salvage surgery for primary sarcomas of the upper limb. J
Plast Reconstr Aesthet Surg. 61:382–387. 2008.
|
|
59
|
Ueda H, Murata H, Takeshita H, Minami G,
Hashiguchi S and Kubo T: Unfiltered xenon light is useful for
photodynamic therapy with acridine orange. Anticancer Res.
25:3979–3983. 2005.
|
|
60
|
Kusuzaki K, Minami G, Takeshita H, et al:
Photodynamic inactivation with acridine orange on a
multidrug-resistant mouse osteosarcoma cell line. Jpn J Cancer Res.
91:439–445. 2000.
|
|
61
|
Wu PK, Chen WM, Chen CF, Lee OK, Haung CK
and Chen TH: Primary osteogenic sarcoma with pulmonary metastasis:
clinical results and prognostic factors in 91 patients. Jpn J Clin
Oncol. 39:514–522. 2009.
|
|
62
|
Asai T, Ueda T, Itoh K, Yoshioka K, Aoki
Y, Mori S and Yoshikawa H: Establishment and characterization of a
murine osteosarcoma cell line (LM8) with high metastatic potential
to the lung. Int J Cancer. 76:418–422. 1998.
|
|
63
|
Satonaka H, Kusuzaki K, Akeda K, et al:
Acridine orange inhibits pulmonary metastasis of mouse
osteosarcoma. Anticancer Res. 31:4163–4168. 2011.
|
|
64
|
Kusuzaki K, Murata H, Matsubara T, et al:
Clinical outcome of a novel photodynamic therapy technique using
acridine orange for synovial sarcomas. Photochem Photobiol.
81:705–709. 2005.
|
|
65
|
Yoshida K, Kusuzaki K, Matsubara T, et al:
Periosteal Ewing’s sarcoma treated by photodynamic therapy with
acridine orange. Oncol Rep. 13:279–282. 2005.
|
|
66
|
Matsubara T, Matsumine A, Kusuzaki K, et
al: A minimally invasive surgery for bone metastases using the
combination of photodynamic therapy and hyperthermia treatment.
Inter J Clin Med. 4:357–363. 2013.
|
